<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Demographic and immunological features of B19V DNA-positive blood donors.</p>
 </caption>
 <alt-text id="alttext0020">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Sample number</th>
    <th rowspan="2">Sex</th>
    <th rowspan="2">Age
     <break/>(years)
    </th>
    <th rowspan="2">IgG</th>
    <th rowspan="2">[IgG] range
     <break/>IU/ml
    </th>
    <th rowspan="2">IgM</th>
    <th rowspan="2">Type of B19V infection</th>
    <th rowspan="2">Pre-transfusion screening
     <xref rid="tbl1fn1" ref-type="table-fn">1</xref>
    </th>
    <th colspan="2">Type of donor
     <hr/>
    </th>
    <th rowspan="2">Destiny of blood components</th>
   </tr>
   <tr>
    <th>Repeat</th>
    <th>First-time</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>79</td>
    <td>F</td>
    <td>43</td>
    <td>NEG</td>
    <td>˂3.0</td>
    <td>NEG</td>
    <td>I</td>
    <td>NEG</td>
    <td>x</td>
    <td/>
    <td>Plasma: manufacturing of blood products.
     <break/>Erythrocytes and platelets: transfusion.
    </td>
   </tr>
   <tr>
    <td>93</td>
    <td>F</td>
    <td>32</td>
    <td>POS</td>
    <td>30.1–50.0</td>
    <td>NEG</td>
    <td>III</td>
    <td>NEG</td>
    <td/>
    <td>x</td>
    <td>Donation interrupted due to bad tolerance.</td>
   </tr>
   <tr>
    <td>101</td>
    <td>M</td>
    <td>50</td>
    <td>POS</td>
    <td>5.1–10.0</td>
    <td>NEG</td>
    <td>III</td>
    <td>NEG</td>
    <td>x</td>
    <td/>
    <td>Plasma: manufacturing of blood products.
     <break/>Erythrocytes and platelets: transfusion.
    </td>
   </tr>
   <tr>
    <td>166</td>
    <td>M</td>
    <td>39</td>
    <td>POS</td>
    <td>10.1–30.0</td>
    <td>NEG</td>
    <td>III</td>
    <td>NEG</td>
    <td>x</td>
    <td/>
    <td>Plasma: manufacturing of blood products.
     <break/>Erythrocytes: transfusion.
    </td>
   </tr>
   <tr>
    <td>353</td>
    <td>M</td>
    <td>53</td>
    <td>POS</td>
    <td>100.0–200.0</td>
    <td>NEG</td>
    <td>III</td>
    <td>NEG</td>
    <td>x</td>
    <td/>
    <td>Erythrocytes and platelets: transfusion.</td>
   </tr>
   <tr>
    <td>536</td>
    <td>M</td>
    <td>37</td>
    <td>POS</td>
    <td>30.1–50.0</td>
    <td>NEG</td>
    <td>III</td>
    <td>NEG</td>
    <td/>
    <td>x</td>
    <td>Plasma: manufacturing of blood products.
     <break/>Erythrocytes and platelets: transfusion.
    </td>
   </tr>
   <tr>
    <td>625</td>
    <td>F</td>
    <td>41</td>
    <td>POS</td>
    <td>30.1–50.0</td>
    <td>NEG</td>
    <td>III</td>
    <td>NEG</td>
    <td/>
    <td>x</td>
    <td>Erythrocytes and plasma: transfusion.</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tbl1fn1">
   <label>1</label>
   <p id="ntpara0010">Pathogens included in pre-transfusion screening tests of local blood banks: Hepatitis B virus, Hepatitis C virus, HIV, HTLV, 
    <italic>Trypanosoma cruzi</italic>
    <italic>, Treponema pallidum</italic>, and 
    <italic>Brucella spp</italic>. NEG: negative; POS: positive. I. ongoing acute infection; III. long-term infection or potentially persistent infection.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
